Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1999-9-28
pubmed:abstractText
Human chorionic gonadotropin (hCG) exists in blood and urine as a variety of isoforms one of which contains peptide bond cleavages within its beta-subunit loop 2 and is referred to as nicked hCG (hCGn). This hCG isoform appears to be more prevalent in the urine of patients with certain malignancies and possibly in some disorders of pregnancy. Until now, only indirect immunoassays could be used to quantify hCGn. We report the development of two monoclonal antibodies (MAbs) to a form of hCGn isolated from a choriocarcinoma patient. This hCG isoform was not only 100% nicked, but also contained 100% tetrasaccharide-core O-linked carbohydrate moieties in its beta COOH-terminal region. Two-site immunometric assays have been developed using these new antibodies, B151 and B152. The former exhibits good specificity for hCGn independent of the source of the hCGn, the form excreted by choriocarcinoma patients or the form of hCGn from normal pregnancies. The latter antibody, B152, is sensitive to the carbohydrate moieties and possibly other differences in hCG isoforms, but is not for nicking of the beta-subunit. These two immunometric assays provide potential novel diagnostic tools for direct measurement of hCG isoforms which could not be accurately quantified earlier before development of the assays using these newly generated antibodies.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1355-008X
pubmed:author
pubmed:issnType
Print
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
137-44
pubmed:dateRevised
2010-6-24
pubmed:meshHeading
pubmed-meshheading:10451222-Animals, pubmed-meshheading:10451222-Antibodies, Monoclonal, pubmed-meshheading:10451222-Antibody Specificity, pubmed-meshheading:10451222-Choriocarcinoma, pubmed-meshheading:10451222-Chorionic Gonadotropin, pubmed-meshheading:10451222-Chorionic Gonadotropin, beta Subunit, Human, pubmed-meshheading:10451222-Down Syndrome, pubmed-meshheading:10451222-Epitope Mapping, pubmed-meshheading:10451222-Female, pubmed-meshheading:10451222-Glycosylation, pubmed-meshheading:10451222-Humans, pubmed-meshheading:10451222-Hydatidiform Mole, pubmed-meshheading:10451222-Mice, pubmed-meshheading:10451222-Peptide Fragments, pubmed-meshheading:10451222-Pre-Eclampsia, pubmed-meshheading:10451222-Pregnancy, pubmed-meshheading:10451222-Radioimmunoassay, pubmed-meshheading:10451222-Tumor Markers, Biological, pubmed-meshheading:10451222-Uterine Neoplasms
pubmed:year
1999
pubmed:articleTitle
Development and characterization of antibodies to a nicked and hyperglycosylated form of hCG from a choriocarcinoma patient: generation of antibodies that differentiate between pregnancy hCG and choriocarcinoma hCG.
pubmed:affiliation
Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA. sb18@columbia.edu
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.